Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro-Oncol 24(Supplement_5):v1-v95. https://doi.org/10.1093/neuonc/noac202
Zhou X, Liao X, Zhang B, He H, Shui Y, Xu W, Jiang C, Shen L, Wei Q (2016) Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy. Mol Clin Oncol 5(2):289–294. https://doi.org/10.3892/mco.2016.936
Article CAS PubMed PubMed Central Google Scholar
Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A (2013) Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg 118(4):812–820. https://doi.org/10.3171/2012.9.JNS1277
Hong B, Wiese B, Bremer M, Heissler HE, Heidenreich F, Krauss JK, Nakamura M (2013) Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme. Am J Clin Oncol 36(3):261–268. https://doi.org/10.1097/COC.0b013e3182467bb1
Djamel-Eddine YC, De Witte O, Melot C, Lefranc F (2019) Recurrent glioblastomas: should we operate a second and even a third time? Interdisciplinary Neurosurgery 18:100551. https://doi.org/10.1016/j.inat.2019.100551
Ringel F, Pape H, Sabel M, Krex D, Bock HC, Misch M, Weyerbrock A, Westermaier T, Senft C, Schucht P, Meyer B, Simon M, SN1 study group (2016) Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. Neuro Oncol 18(1):96-104.https://doi.org/10.1093/neuonc/nov145
Krajewski S, Furtak J, Zawadka-Kunikowska M, Kachelski M, Birski M, Harat M (2022) Rehabilitation outcomes for patients with motor deficits after initial and repeat brain tumor surgery. Int J Environ Res Public Health 19(17):10871. https://doi.org/10.3390/ijerph191710871
Article PubMed PubMed Central Google Scholar
Yang K, Ellenbogen Y, Martyniuk A, Sourour M, Takroni R, Somji M, Gardiner E, Hui K, Odedra D, Larrazabal R, Algird A, Kachur E, Reddy K, Murty N, Farrokhyar F, Singh SK (2022) Reoperation in adult patients with recurrent glioblastoma: A matched cohort analysis. Neurooncol Adv 4(1):vdac115. https://doi.org/10.1093/noajnl/vdac115
Hoover JM, Nwojo M, Puffer R, Mandrekar J, Meyer FB, Parney IF (2013) Surgical outcomes in recurrent glioma: clinical article. J Neurosurg 118(6):1224–1231. https://doi.org/10.3171/2013.2.JNS121731
McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A (2009) Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65(3):463–470. https://doi.org/10.1227/01.NEU.0000349763.42238.E9
Rahman M, Abbatematteo J, De Leo EK, Kubilis PS, Vaziri S, Bova F, Sayour E, Mitchell D, Quinones-Hinojosa A (2017) The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. J Neurosurg 127(1):123–131. https://doi.org/10.3171/2016.7.JNS16396
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106
Article CAS PubMed PubMed Central Google Scholar
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579. https://doi.org/10.1200/JCO.1993.11.3.570
Article CAS PubMed Google Scholar
Henneghan AM, Van Dyk K, Kaufmann T, Harrison R, Gibbons C, Heijnen C, Kesler SR (2021) Measuring self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group. J Natl Cancer Inst 113(12):1625–1633. https://doi.org/10.1093/jnci/djab027
Article PubMed PubMed Central Google Scholar
Dyk KV, Crespi CM, Petersen L, Ganz PA (2019) Identifying cancer-related cognitive impairment using the FACT-Cog perceived cognitive impairment. JNCI Cancer Spectr 4(1):pkz099. https://doi.org/10.1093/jncics/pkz099
Edianto D, Yaznil MR, Chartyansari AA, Effendi IH (2019) Assessment of the quality of life for gynecologic cancer patients using functional assessment of cancer therapy-general (Fact-G) questionnaire at Haji Adam Malik Hospital. Open Access Maced J Med Sci 7(16):2569–2573. https://doi.org/10.3889/oamjms.2019.391
Article PubMed PubMed Central Google Scholar
Janelsins MC, Heckler CE, Peppone LJ, Kamen C, Mustian KM, Mohile SG, Magnuson A, Kleckner IR, Guido JJ, Young KL, Conlin AK, Weiselberg LR, Mitchell JW, Ambrosone CA, Ahles TA, Morrow GR (2016) Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a Nationwide, multicenter, Prospective Longitudinal Study. J Clin Oncol 35(5):506–514. https://doi.org/10.1200/JCO.2016.68.5826
Article PubMed PubMed Central Google Scholar
King MT, Cella D, Osoba D, Stockler M, Eton D, Thompson J, Eisenstein A (2010) Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire. Patient Relat Outcome Meas 1:119–126. https://doi.org/10.2147/PROM.S10621
Article PubMed PubMed Central Google Scholar
Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, Winocur G, De Ruiter MB, Castel H (2019) Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol 30(12):1925–1940. https://doi.org/10.1093/annonc/mdz410
Article CAS PubMed Google Scholar
Yost KJ, Thompson CA, Eton DT, Allmer C, Ehlers SL, Habermann TM, Shanafelt TD, Maurer MJ, Slager SL, Link BK, Cerhan JR (2013) The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma 54(2):290–297. https://doi.org/10.3109/10428194.2012.711830
Beck AT, Steer RA, Brown GK (1996) Manual for the Beck depression inventory-II. Psychological Corporation, San Antonio, Texas
Beck AT, Steer RA (1993) Beck anxiety inventory. Psychological Corporation, San Antonia, Texas
McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63(4):700–708. https://doi.org/10.1227/01.NEU.0000325729.41085.73
Pertz M, Schlegel U, Thoma P (2022) Sociocognitive functioning and psychosocial burden in patients with brain tumors. Cancers 14(3):767. https://doi.org/10.3390/cancers14030767
Article PubMed PubMed Central Google Scholar
Jenkins LM, Drummond KJ, Andrewes DG (2016) Emotional and personality changes following brain tumour resection. J Clin Neurosci 29:128–213. https://doi.org/10.1016/j.jocn.2015.12.007
Cuevas H, Danesh V, Henneghan A (2022) Self-reported cognitive function in persons with nonneurological chronic diseases: a systematic review. J Aging Res 2022:5803337. https://doi.org/10.1155/2022/5803337
Article PubMed PubMed Central Google Scholar
Ramasubbu SK, Pasricha RK, Nath UK, Rawat VS, Das B (2021) Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital. Cancer Rep (Hoboken) 4(2):e1312. https://doi.org/10.1002/cnr2.1312
留言 (0)